Carie Boydâ€s Prescription Shop Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Carie Boydâ€s Prescription Shop's estimated annual revenue is currently $6M per year.(i)
  • Carie Boydâ€s Prescription Shop's estimated revenue per employee is $201,000

Employee Data

  • Carie Boydâ€s Prescription Shop has 30 Employees.(i)
  • Carie Boydâ€s Prescription Shop grew their employee count by -9% last year.

Carie Boydâ€s Prescription Shop's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
Director Quality ControlReveal Email/Phone
3
Digital Marketing ManagerReveal Email/Phone
4
Non Sterile Lab TechnitianReveal Email/Phone
5
Pharmaceutical Sales RepresentativeReveal Email/Phone
6
Technical WriterReveal Email/Phone
7
Human Resources AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.7M13320%N/AN/A
#2
$13.5M676%N/AN/A
#3
$16.1M80-2%N/AN/A
#4
$62.5M0N/AN/AN/A
#5
$10.1M506%N/AN/A
#6
$119.4M59427%N/AN/A
#7
$22.9M1148%N/AN/A
#8
$92.9M4628%N/AN/A
#9
$11.3M56-8%N/AN/A
#10
$7M356%N/AN/A
Add Company

What Is Carie Boydâ€s Prescription Shop?

We are a state-of-the-art, FDA registered 503B outsourcing facility that provides healthcare practitioners, clinics, hospitals, Group Purchasing Organizations, and other provider networks with the highest-quality manufactured medications. We also have a 503A compounding pharmacy, which gives us the unique ability to provide our healthcare partners and their patients with nearly any custom manufactured or compounded medication they need. We were founded in 1965 as a small community pharmacy, serving the local Dallas-Ft. Worth area. We started working with general practitioners, urologists, and OB-GYNs, and quickly became known for our hormone medications. Soon, we were one of the leading suppliers of implantable subcutaneous hormone pellets as we innovated the modern automated pellet manufacturing process. In 2015, we became one of the earliest independently-owned facilities to register with the FDA as a 503B outsourcing facility, and by 2019, we had moved into our current facility in order to increase our manufacturing capacity and support our growing team of professionals. Today, as one of the leaders in our industry, we continue to look for opportunities to serve our healthcare partners. Whether we are compounding a routine prescription or having our team of research and development pharmacists develop a new 503B product, our commitment is to provide our partners and the healthcare system in general with superior quality, service, and innovation

keywords:N/A

N/A

Total Funding

30

Number of Employees

$6M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M30-14%N/A
#2
$5.3M3011%N/A
#3
$3.6M31N/AN/A
#4
$3.7M313%N/A
#5
$3.6M31N/AN/A